Skip to main content
Top

Drugs

Issue 3/2017

Content (9 Articles)

Early Combination Therapy with Oral Glucose-Lowering Agents in Type 2 Diabetes

  • Leading Article

Cristina Bianchi, Giuseppe Daniele, Angela Dardano, Roberto Miccoli, Stefano Del Prato

Drug Therapy for Stable Angina Pectoris

  • Therapy in Practice

Talla A. Rousan, Sunil T. Mathew, Udho Thadani

Pharmacological Management of Chronic Pelvic Pain in Women

  • Review Article

Erin T. Carey, Sara R. Till, Sawsan As-Sanie

The Ocular Manifestations of Drugs Used to Treat Multiple Sclerosis

  • Review Article

Gregory Heath, Archana Airody, Richard Peter Gale

Eight- or 12-Week Treatment of Hepatitis C with Ledipasvir/Sofosbuvir: Real-World Experience in a Large Integrated Health System

  • Original Research Article

Jennifer B. Lai, Maxwell A. Witt, Mary Patricia Pauly, Joanna Ready, Michael Allerton, Suk Seo, David J. Witt

Saxagliptin/Dapagliflozin: A Review in Type 2 Diabetes Mellitus

  • Adis Drug Evaluation

Karly P. Garnock-Jones

Dabigatran Etexilate: A Review in Nonvalvular Atrial Fibrillation

  • Adis Drug Evaluation

Hannah A. Blair, Gillian M. Keating

Teduglutide: A Review in Short Bowel Syndrome

  • Adis Drug Evaluation

Esther S. Kim, Susan J. Keam

Keynote webinar | Spotlight on dry eye disease

  • Live
  • Webinar | 28-05-2026 | 13:00 (CEST)

DED is highly prevalent yet challenging to diagnose and treat. Join leading experts to explore the latest developments and gain practical guidance on effective management in busy clinical settings. Brought to you by Springer Medicine and Eye.

Watch it live: 28 May 2026, 13:00–14:00 (CEST)

Prof. Harminder Dua
Prof. Sajjad Ahmad
Prof. Anat Galor
Join the webinar
Webinar
Image Credits
Conceptual illustration of dry eye disease/© Science Photo Library / Getty Images